Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4044254
[patent_doc_number] => 05912170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Redirection of cellular immunity by protein-tyrosine kinase chimeras'
[patent_app_type] => 1
[patent_app_number] => 8/394177
[patent_app_country] => US
[patent_app_date] => 1995-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 20059
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912170.pdf
[firstpage_image] =>[orig_patent_app_number] => 394177
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/394177 | Redirection of cellular immunity by protein-tyrosine kinase chimeras | Feb 23, 1995 | Issued |
Array
(
[id] => 3705544
[patent_doc_number] => 05675062
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Cellular basis of transplant arteriosclerosis in mice'
[patent_app_type] => 1
[patent_app_number] => 8/377305
[patent_app_country] => US
[patent_app_date] => 1995-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 11413
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/675/05675062.pdf
[firstpage_image] =>[orig_patent_app_number] => 377305
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/377305 | Cellular basis of transplant arteriosclerosis in mice | Jan 23, 1995 | Issued |
Array
(
[id] => 3735607
[patent_doc_number] => 05698531
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor'
[patent_app_type] => 1
[patent_app_number] => 8/376522
[patent_app_country] => US
[patent_app_date] => 1995-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9696
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698531.pdf
[firstpage_image] =>[orig_patent_app_number] => 376522
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/376522 | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor | Jan 22, 1995 | Issued |
08/366787 | NUCLEIC ACID CONDENSING AGENTS WITH REDUCED IMMUNOGENICITY | Dec 29, 1994 | Abandoned |
08/367071 | PRODUCTION AND ADMINISTRATION OF HIGH TITER RECOMBINANT RETROVIRUSES | Dec 29, 1994 | Abandoned |
08/368210 | COMBINATION GENE DELIVERY VEHICLES | Dec 29, 1994 | Abandoned |
Array
(
[id] => 3720341
[patent_doc_number] => 05681562
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Lymphokine gene therapy of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/352990
[patent_app_country] => US
[patent_app_date] => 1994-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13906
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681562.pdf
[firstpage_image] =>[orig_patent_app_number] => 352990
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/352990 | Lymphokine gene therapy of cancer | Dec 8, 1994 | Issued |
08/348960 | TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS | Nov 27, 1994 | Abandoned |
Array
(
[id] => 3936889
[patent_doc_number] => 05871959
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Method of producing hepatocycte growth factor/scatter factor and related cell lines'
[patent_app_type] => 1
[patent_app_number] => 8/344710
[patent_app_country] => US
[patent_app_date] => 1994-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 58
[patent_no_of_words] => 19088
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871959.pdf
[firstpage_image] =>[orig_patent_app_number] => 344710
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/344710 | Method of producing hepatocycte growth factor/scatter factor and related cell lines | Nov 17, 1994 | Issued |
Array
(
[id] => 3799793
[patent_doc_number] => 05830463
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Yeast-based delivery vehicles'
[patent_app_type] => 1
[patent_app_number] => 8/340185
[patent_app_country] => US
[patent_app_date] => 1994-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17444
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830463.pdf
[firstpage_image] =>[orig_patent_app_number] => 340185
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/340185 | Yeast-based delivery vehicles | Nov 14, 1994 | Issued |
Array
(
[id] => 3787295
[patent_doc_number] => 05736524
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Polynucleotide tuberculosis vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/338992
[patent_app_country] => US
[patent_app_date] => 1994-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 11141
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736524.pdf
[firstpage_image] =>[orig_patent_app_number] => 338992
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338992 | Polynucleotide tuberculosis vaccine | Nov 13, 1994 | Issued |
Array
(
[id] => 3999681
[patent_doc_number] => 05858771
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Products and methods for controlling the suppression of the neoplastic phenotype'
[patent_app_type] => 1
[patent_app_number] => 8/337855
[patent_app_country] => US
[patent_app_date] => 1994-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 19700
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858771.pdf
[firstpage_image] =>[orig_patent_app_number] => 337855
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/337855 | Products and methods for controlling the suppression of the neoplastic phenotype | Nov 13, 1994 | Issued |
08/318248 | HEPATITIS C VIRUS VACCINE | Oct 4, 1994 | Abandoned |
Array
(
[id] => 3888278
[patent_doc_number] => 05834293
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Cytochrome P450 arachidonic acid epoxygenase genetic mutation associated with hypertension'
[patent_app_type] => 1
[patent_app_number] => 8/314601
[patent_app_country] => US
[patent_app_date] => 1994-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12241
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834293.pdf
[firstpage_image] =>[orig_patent_app_number] => 314601
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/314601 | Cytochrome P450 arachidonic acid epoxygenase genetic mutation associated with hypertension | Sep 27, 1994 | Issued |
08/277489 | TRANSPLANT ARTERIOSCLEROSIS | Jul 17, 1994 | Abandoned |
Array
(
[id] => 3975590
[patent_doc_number] => 05958403
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Methods and compounds for prevention of graft rejection'
[patent_app_type] => 1
[patent_app_number] => 8/273402
[patent_app_country] => US
[patent_app_date] => 1994-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 17505
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958403.pdf
[firstpage_image] =>[orig_patent_app_number] => 273402
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/273402 | Methods and compounds for prevention of graft rejection | Jul 10, 1994 | Issued |
Array
(
[id] => 3820773
[patent_doc_number] => 05759535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Immunotherapeutic strategies for the treatment of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/242405
[patent_app_country] => US
[patent_app_date] => 1994-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 7797
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759535.pdf
[firstpage_image] =>[orig_patent_app_number] => 242405
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/242405 | Immunotherapeutic strategies for the treatment of cancer | May 12, 1994 | Issued |
08/234145 | GENERATION OF XENOGENEIC ANTIBODIES | Apr 27, 1994 | Abandoned |
Array
(
[id] => 3685868
[patent_doc_number] => 05643746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Human epidermal gene promoter'
[patent_app_type] => 1
[patent_app_number] => 8/216219
[patent_app_country] => US
[patent_app_date] => 1994-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9283
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643746.pdf
[firstpage_image] =>[orig_patent_app_number] => 216219
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/216219 | Human epidermal gene promoter | Mar 20, 1994 | Issued |
Array
(
[id] => 3723207
[patent_doc_number] => 05681747
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof'
[patent_app_type] => 1
[patent_app_number] => 8/199779
[patent_app_country] => US
[patent_app_date] => 1994-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6198
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681747.pdf
[firstpage_image] =>[orig_patent_app_number] => 199779
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/199779 | Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof | Feb 21, 1994 | Issued |